Short report
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
1 Department of Clinical Sciences, Pathology, Lund University, Skåne University Hospital, 221 85 Lund, Sweden
2 Department of Clinical Sciences, Division of Urological Cancers, Lund University, Skåne University Hospital, 205 02 Malmö, Sweden
3 Department of Proteomics, AlbaNova University Center, Royal Institute of Technology, 106 91 Stockholm, Sweden
4 Science for Life Laboratory, Royal Institute of Technology, 106 91 Stockholm, Sweden
Diagnostic Pathology 2011, 6:91 doi:10.1186/1746-1596-6-91
Published: 28 September 2011Additional files
Additional file 1:
Patient and tumour characteristics.
Format: DOC Size: 45KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Association between RBM3 and clinicopathological parameters.
Format: DOC Size: 68KB Download file
This file can be viewed with: Microsoft Word Viewer
